A particular focus on gastric adenocarcinoma – a major cause of global morbidity and mortality – reveals that FZD2 overexpression activates oncogenic pathways (Wnt/β-catenin and Notch) and induces EMT, thereby promoting metastasis and chemoresistance. This evidence concerns the gene FZD2 and gastric adenocarcinoma.